Biotech Layoff Tracker 2025. One report estimates the pharma industry will spend $4.5 billion on digital transformation by 2030; Around 40% of the german biotech’s employees will be let go in 2025—a “difficult decision to make,” according to ceo selwyn ho, who nevertheless noted that the layoffs are “a necessary step to ensure the long.
Furthermore, in 2022, the ipo market plummeted, with volatility and market uncertainty driving. Using data from fierce biotech’s layoff tracker, gabrielle masson and max bayer analyze the trends of layoffs in the first quarter of 2024, comparing them to previous years.